Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials

Matti Lehtinen,Camilla Lagheden,Marjo Kuortti,Joakim Dillner,Katja Harjula,Tiina Eriksson,Tiina Petäjä,Gary Dubin,Tapio Luostarinen,Mari Siitari-Mattila,Dan Apter,Jorma Paavonen,Eero Pukkala,Pekka Nieminen,Frank Struyf,Johanna Palmroth,Kari Natunen

doi:10.1136/bmjopen-2017-015867

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials

Matti Lehtinen, Camilla Lagheden + Show 15 more

Open Access

https://doi.org/10.1136/bmjopen-2017-015867

Copy DOI

Journal: BMJ Open	Publication Date: Aug 1, 2017
Citations: 68	License type: open-access

Affiliation: Karolinska Institutet, Tampere University, Takeda (Switzerland), VL-Medi Oy (Finland), University of Helsinki, Finnish Cancer Registry, Q-Biologicals (Belgium)

#Cervical Intraepithelial Neoplasia Grade 3 #Unvaccinated Women + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectiveDue to long lag time between infection/cancer diagnoses human papillomavirus (HPV) vaccination programs will deliver vaccine efficacy (VE) estimates against cancer end-points late. Cancer registry follow-up of population-based, randomised trial...

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: BMJ Open

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.